Completed dose finding phase and confirmed the recommended Phase 2 dose (RP2D) in its ongoing Phase 1 clinical trial of SENTI-202 (NCT06325748) for the treatment of relapsed/refractory hematologic ...

As previously announced, Perimeter Solutions management will hold a conference call at 8:30 a.m. ET on Thursday, August 7, 2025 to discuss financial results for the second quarter 2025. The conference ...

Pink signs posted in front of homes and businesses across Severna Park are the subject of a letter that serves as notice of possible legal action.

CNW/ - Allied Gold Corporation (TSX: AAUC) (NYSE: AAUC) ("Allied" or the "Company") reports second quarter of 2025 production ...